CFTR and cystic fibrosis: Correction with VX‐809 and potentiation with VX‐770 increased the functional expression of the rare mutant CFTR, but this rescued function was modest at ~50% of the rescue measured in nasal cultures from ΔF508 homozygous patients and < 20% of the minimum CFTR function observed in non‐CF family members.